New drug slows down primary progressive MS for first time offering 'hope for future'
The drug ocrelizumab has been found to reduce the progression of Multiple Sclerosis by 25 per cent in people with primary progressive MS.
Source: Care Feeds
Our Office
Our Office is Open from 9 am-5 pm Mon to Fri
ICare Nottingham Ltd
172 Derby Road,
Lenton Nottingham
NG7 1LR
T: 0115 9782403
Email: a.hussain@icarenottingham.co.uk
Email: recruitment@icarenottingham.co.uk